Published on 13th April 2012
Latest comparative research shows that hydrogen peroxide vapor (HPV) technology is more effective at reducing bacterial contamination in hospitals than ultraviolet light-based (UVC) systems.
The head-to-head study published in Infection Control and Hospital Epidemiology, was conducted by leading infection control practitioners at the Hospital of Saint Raphael and Yale University School of Medicine, both in New Haven, Connecticut. Their results showed that Bioquell’s HPV was significantly more effective for reducing biological contamination, including spores, in patient rooms compared with a UVC system. This was especially evident for areas that were out of direct line of sight of the UVC system. Overall, half of the surfaces contaminated with bacteria before exposure to UVC remained contaminated after UVC exposure.
Published on 7th March 2012
In the United States, healthcare associated infections (HAIs) and their cost to the healthcare system are staggering. The CDC estimates that approximately 1 in every 20 hospitalized patients will contract an HAI. Cost estimates range upward of $40 billion dollars annually in the fight against HAIs. Recently released CDC statistics show infection rates and deaths from HAIs climbing. Deaths attributed with Clostridium difficile infection rates alone have jumped to a range of 14,000 per year. To help in the fight against HAIs, Bioquell has launched its educational Bug Stoppers campaign.
Published on 5th March 2012
A recent independent study confirms hydrogen peroxide vapor technology as superior to the aerosolized hydrogen peroxide process. A team at St. George’s Hospital, London, UK, unquestionably established that hydrogen peroxide vapor (HPV) technology from Bioquell is faster, safer, and more effective for room biodecontamination than aerosolized hydrogen peroxide (aHP).
Published on 7th February 2012
The latest generation hydrogen peroxide bio-decontamination technology from Bioquell has now achieved Australian C-Tick approval. The C-Tick mark provides assurance that products have been tested to the appropriate standards for conformity to the EMC (Electro Magnetic Compatibility) and Radio Telecommunications standards by a registered testing laboratory.
Published on 18th January 2012
Bioquell announces that it has been awarded a £1.2 million development contract relating to the new vehicle being developed by General Dynamics UK for the UK Ministry of Defense.
Published on 4th January 2012
Cutting edge bio-decontamination technology now interfaces with market leading data logging system to provide robust and secure information capture for the life science and pharmaceutical markets.
Published on 18th November 2011
Covering a wide range of microbes, experts from leading environmental bio-contamination specialist, Bioquell, have developed a comprehensive and freely available online ‘bug’ database. The micro site features over 30 of the most common environmental contaminants and provides valuable insight into the world of bacteria, viruses, and fungi.
Published on 18th November 2011
To avoid the world coming under threat from untreatable infections, more focus on the management of the environment is essential claims a leading expert. Superbugs are becoming more resistant to the current portfolio of antibiotics and investment in developing new drugs has been scaled back. Minimizing the risk of pathogen transfer from healthcare surroundings to the patient needs to be a key focus to help prevent unwanted infections.
Published on 20th October 2011
Hydrogen peroxide bio-decontamination technology is one of the hot topics at this year’s 49th Annual Meeting of the Infectious Diseases Society of America and the HIV Medicine Association. Three scientific abstracts are being presented on hydrogen peroxide vapor (HPV) at the meeting in Boston, Massachusetts on October 20-23, 2011.
Published on 19th October 2011
With a continual rise in multidrug-resistant germs, a new website has been launched to raise awareness of many of the main pathogens that cause healthcare associated infections (HAIs). Designed to help healthcare professionals and ancillary staff, www.bugstoppersusa.com has been specially developed to provide easy-to-digest information on the illicit antics of nosocomial pathogens such as Clostridium difficile, MRSA, Klebsiella pneumoniae and norovirus.